◆英語タイトル：OncoTherapy Science Inc (4564) - Financial and Strategic SWOT Analysis Review
OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and development activities to develop its anti-cancer drug by providing technology platforms that include laser micro-beam microdissection, cDNA microarray and identification of target genes. The company partners with other healthcare industries to test and develop vaccines for increasing the efficiency of treating cancer. It holds interest in genome analysis of liquid biopsy, cancer and immunotherapy including development of neoantigen prediction. OncoTherapy is headquartered in Kawasaki, Japan.
OncoTherapy Science Inc Key Recent Developments
Nov 30,2018: 30/11/2018 Announcement of a commissioned basic contract between OTS’s subsidiary company and Cosmo Bio Co., Ltd. for peptide synthesis
Nov 20,2018: IR News 20/11/2018 The announcement of the additional investigational site opening of Phase I clinical study for OTS167 (oral administration) in patients with Breast Cancer including Triple-Negative Breast Cancer
Aug 08,2018: OncoTherapy: Publication of a paper on the development of small molecule compounds inhibiting a novel anti-cancer drug target
Feb 15,2018: Announcement of partnership between OTS’s subsidiary company and Thermo Fisher Scientific to evaluate new liquid biopsy platform
This comprehensive SWOT profile of OncoTherapy Science Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OncoTherapy Science Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
OncoTherapy Science Inc – Key Information
OncoTherapy Science Inc – Overview
OncoTherapy Science Inc – Key Employees
OncoTherapy Science Inc – Key Employee Biographies
OncoTherapy Science Inc – Key Operational Heads
OncoTherapy Science Inc – Major Products and Services
OncoTherapy Science Inc – History
OncoTherapy Science Inc – Company Statement
OncoTherapy Science Inc – Locations And Subsidiaries
OncoTherapy Science Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
OncoTherapy Science Inc – Business Description
OncoTherapy Science Inc – Corporate Strategy
OncoTherapy Science Inc – SWOT Analysis
SWOT Analysis – Overview
OncoTherapy Science Inc – Strengths
OncoTherapy Science Inc – Weaknesses
OncoTherapy Science Inc – Opportunities
OncoTherapy Science Inc – Threats
OncoTherapy Science Inc – Key Competitors
Section 3 – Company Financial Performance Charts
OncoTherapy Science Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
OncoTherapy Science Inc, Key Information
OncoTherapy Science Inc, Key Ratios
OncoTherapy Science Inc, Share Data
OncoTherapy Science Inc, Major Products and Services
OncoTherapy Science Inc, History
OncoTherapy Science Inc, Key Employees
OncoTherapy Science Inc, Key Employee Biographies
OncoTherapy Science Inc, Key Operational Heads
OncoTherapy Science Inc, Other Locations
OncoTherapy Science Inc, Subsidiaries
OncoTherapy Science Inc, Key Manufacturing facilities
OncoTherapy Science Inc, Key Competitors
OncoTherapy Science Inc, SWOT Analysis
OncoTherapy Science Inc, Ratios based on current share price
OncoTherapy Science Inc, Annual Ratios
OncoTherapy Science Inc, Interim Ratios
Capital Market Ratios
List of Figures
OncoTherapy Science Inc, Performance Chart
OncoTherapy Science Inc, Ratio Charts
| ★海外企業調査レポート[OncoTherapy Science Inc (4564)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら